Literature DB >> 2745159

Autoradiographic localization of [3H]hydroxytamoxifen to uterine oestrogen- and antioestrogen-binding sites.

B W Ennis1, W E Stumpf.   

Abstract

Immature rats were injected subcutaneously with 0.36 micrograms of [3H]hydroxytamoxifen ([3H]TAM(OH)) or 0.24 microgram of [3H]oestradiol in oil, and 4 h later uteri were processed for thaw-mount autoradiography. The specificity of [3H]TAM(OH) localization was determined by injecting a 200-fold excess of unlabelled TAM(OH) or a 20-, 200- or 2000-fold excess of oestradiol 1 h before injection of [3H]TAM(OH). After injection of [3H]TAM(OH) or [3H]oestradiol, autoradiograms showed concentration of radioactivity in nuclei of stromal, epithelial and myometrial cells, but this labelling varied among the cell types depending upon which compound was injected. After [3H]TAM(OH) injection, the decreasing order of labelling intensity was stroma, myometrium, epithelium; after [3H]oestradiol injection the decreasing order was stroma, epithelium, myometrium. Injection of TAM(OH) before [3H]TAM(OH) eliminated nuclear labelling in all the uterine cell types. Injection of oestradiol before [3H]TAM(OH) decreased nuclear labelling and resulted in the concentration of label in the cytoplasm of luminal epithelium which was not present when [3H]TAM(OH) was injected alone. Cytoplasmic labelling increased initially as the oestradiol competition dose increased, but the increase in labelling did not continue with increasing concentrations of oestradiol. The results indicate that antioestrogen and oestrogen localize to nuclei of the same uterine cell types, but that cellular uptake differs among the tissue compartments. The results also suggest that a high concentration of antioestrogen-binding sites exist in the cytoplasm of the uterine luminal epithelium.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2745159     DOI: 10.1007/bf01002472

Source DB:  PubMed          Journal:  Histochem J        ISSN: 0018-2214


  30 in total

1.  Autoradiographic techniques for localizing steroid hormones.

Authors:  W E Stumpf; M Sar
Journal:  Methods Enzymol       Date:  1975       Impact factor: 1.600

2.  Non-steroidal antioestrogens--receptor binding and biological response in rat uterus, rat mammary carcinoma and human breast cancer cells.

Authors:  A E Wakeling; B Valcaccia; E Newboult; L R Green
Journal:  J Steroid Biochem       Date:  1984-01       Impact factor: 4.292

3.  Antiestrogen pharmacology and mechanism of action.

Authors:  B S Katzenellenbogen; M A Miller; R L Eckert; K Sudo
Journal:  J Steroid Biochem       Date:  1983-07       Impact factor: 4.292

4.  Antiestrogen-binding sites distinct from the estrogen receptor: subecellular localization, ligand specificity, and distribution in tissues of the rat.

Authors:  K Sudo; F J Monsma; B S Katzenellenbogen
Journal:  Endocrinology       Date:  1983-02       Impact factor: 4.736

5.  Binding of [3H]monohydroxytamoxifen by immature rat tissues in vivo.

Authors:  V C Jordan; R A Bowser-Finn
Journal:  Endocrinology       Date:  1982-04       Impact factor: 4.736

6.  Effects of estrogens and antiestrogens on estrogen receptor dynamics and the induction of progesterone receptor in MCF-7 human breast cancer cells.

Authors:  R L Eckert; B S Katzenellenbogen
Journal:  Cancer Res       Date:  1982-01       Impact factor: 12.701

7.  An evaluation of the role of antiestrogen-binding sites in mediating the growth modulatory effects of antiestrogens: studies using t-butylphenoxyethyl diethylamine, a compound lacking affinity for the estrogen receptor.

Authors:  Y Y Sheen; D M Simpson; B S Katzenellenbogen
Journal:  Endocrinology       Date:  1985-08       Impact factor: 4.736

8.  Primary cultures of estrogen-responsive cells from rat uteri: induction of progesterone receptors and a secreted protein.

Authors:  J A Kassis; D Sakai; J H Walent; J Gorski
Journal:  Endocrinology       Date:  1984-05       Impact factor: 4.736

9.  New evidence that the antiestrogen binding site may be a novel growth-promoting histamine receptor (?H3) which mediates the antiestrogenic and antiproliferative effects of tamoxifen.

Authors:  L J Brandes; R P Bogdanovic
Journal:  Biochem Biophys Res Commun       Date:  1986-01-29       Impact factor: 3.575

10.  trans-4-Hydroxytamoxifen concentration and metabolism after local percutaneous administration to human breast.

Authors:  P Mauvais-Javis; N Baudot; D Castaigne; P Banzet; F Kuttenn
Journal:  Cancer Res       Date:  1986-03       Impact factor: 12.701

View more
  1 in total

1.  Effects of chronic oestrogen treatment are not selective for uterine noradrenaline-containing sympathetic nerves: a transplantation study.

Authors:  M M Brauer; R Chávez-Genaro; J Llodrá; A Richeri; M C Scorza
Journal:  J Anat       Date:  2000-04       Impact factor: 2.610

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.